期刊文献+

聚酰胺-胺型树状高聚物介导短发卡RNA转染小鼠腹膜组织的实验研究 被引量:2

Transfer of plasmid expressing short hair RNA into mouse peritoneum mediated by polyamidoamine dendrimers
下载PDF
导出
摘要 目的研究聚酰胺-胺型树状高聚物(PAMAM)载体介导pHK-shRNA质粒在小鼠腹膜组织的表达情况。方法将昆明小鼠随机分为转染组和对照组,分别经腹腔注射PAMAM G9/pHK-shRNA复合物或生理盐水,于24h、48h、96h和168h留取壁层和脏层腹膜组织,在荧光显微镜下观察壁层腹膜绿色荧光蛋白(GFP)的表达,同时采用Western Blot检测脏层腹膜GFP的表达。结果正常对照组的小鼠腹膜组织未能检测到GFP表达,而PAMAM G9/pHK-shRNA转染组的各时间点均可检测到GFP表达,以48h表达最强,显著高于其他各时间点(P<0.01)。Western Blot结果与冰冻组织切片的结果一致。结论PAMAM载体可介导pHK-shRNA转染正常小鼠的腹膜组织,为进一步体内研究提供实验依据。 Objective To investigate the expression of pHK-shRNA plasmid mediated by polyamidoamine dendrimers(PAMAM)in mouse peritoneum. Methods Kunming mice were randomly divided into transfection group and control group, and were intraperitoneally injected with PAMAM G9/pHK-shRNA complex and saline, respectively. Parietal and visceral peritoneum were collected after the injection for 24h, 48h, 96h and 7d, and the expression of green fluorescent protein (GFP) in peritoneum was detected by fluorescence microscope and western blot. Results Expression of GFP was not detected in control group, and was detected in peritoneum of transfection group at all time points. Western blot and observation of tissue sections showed that the peak of the expression was at 48h after the transfection. Conclusion pHK-shRNA plasmid can be efficiently transferred into mouse peritoneal tissue by PAMAM, which provides an approach for in vivo experimental studies.
出处 《中国血液净化》 2008年第3期145-148,共4页 Chinese Journal of Blood Purification
关键词 聚酰胺-胺型树状高聚物 腹膜组织 转染 Polyamidoamine dendrimers (PAMAM) Peritoneal tissue Transfection
  • 相关文献

参考文献14

  • 1Vasir JK, Labhasetwar V. Polymeric nanoparticles for gene delivery[J]. Expert Opin Drug Deliv, 2006, 3(3):325-344.
  • 2Tomalia DA, Baker J, Dewald J, et al. A New Class of Polymers: Starburst dendritic Macromolecules[J]. Polymer Journal, 1985, 17: 117-132.
  • 3Yang H, Kao WJ. Dendrimers for pharmaceutical and biomedical applications[J]. J Biomater Sci Polym Ed, 2006, 17(1- 2) :3-19.
  • 4Kukowska-Latallo JF, Bielinska AU, Johnson J, et al. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers[J]. Proc Natl Acad Sci USA, 1996, 93(10): 4897-4902.
  • 5Bielinska A, Kukowska Latallo JF, Johnson J, et al.The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis Of alterations induced in nuclease sensitivity and transcripitional activity of the complexed DNA[J].Nucleic Acids Res, 1996,: 24 (11): 2176-2182.
  • 6郭晨莹,王恒,蔺亚晖,蔡启良.应用PAMAM dendrimers作为DNA运送载体的体外研究[J].生物化学与生物物理进展,2004,31(9):804-811. 被引量:5
  • 7Kitchens KM, Kolhatkar RB, Swaan PW, et al. Transport of poly (amidoamine) dendrimers across Caco-2 cell monolayers: Influence of size, charge and fluorescent labeling[J].Pharm Res, 2006, 23(12):2818-2826.
  • 8Teixeira LA, Fricke CH, Bonorino CB, et al. An efficlent gene transfer system for hematopoietic cell Iine using transient and stable vectors[J]. J Biotechnol, 2001, 88 (2): 159-165.
  • 9Choi Y, Thomas T, Kotlyar A, et al. Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting[J]. Chem Biol, 2005, 12 (1): 35-43.
  • 10Bielinska AU, Yen A, Wu HL, et al. Application of membranebased dendrimer/DNA complexes for solid phase transfection in vitro and in vivo[J]. Biomaterials, 2000, 21(9): 877- 887.

二级参考文献34

  • 1Bronte V. Genetic vaccination for the active immunotherapy of cancer. Curr Gene Ther, 2001, 1 (1): 53 - 100
  • 2Lundstrom K. Alphavirus vectors for gene therapy applications.Curr Gene Ther, 2001, 1 (1): 19 -29
  • 3Robinson H L. New hope for an AIDS vaccine. Nat Rev Immunol,2002,2 (4): 239-250
  • 4Yamamoto S, Yamamoto T, Nojima Y, et al. Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development. Jpn J Infect Dis, 2002, 55 (2): 37 -44
  • 5Minichiello V. New vaccine technology-what do you need to know? J Am Acad Nurse Pract, 2002, 14 (2): 73 -81
  • 6Gao X, Huang L. Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry, 1996, 35:1027 - 1036
  • 7Rajur S B, Roth C M, Morgan J R, et al. Covalent proteinoligonucleotide conjugates for efficient delivery of antisense molecules. Bioconjug Chem, 1997, 8: 935 -940
  • 8Brazeau G A, Attia S, Poxon S, et al. In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery.Pharm Res, 1998, 15 (5): 680 -684
  • 9Fischer D, Bieber T, Li Y, et al. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine:effect of molecular weight on transfection efficiency and cytotoxicity.Pharm Res, 1999, 16:1272~1278
  • 10Hughes J A, Aronsohn A I, Avrutskaya A V, et al. Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides. Pharm Res, 1996, 13 (3):404 -410

共引文献7

同被引文献74

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部